Literature DB >> 964988

The human leukocyte test system. IX. DNA synthesis and mitoses in PHA-stimulated 2-day cultures set up with Eagle's mimimal essential medium (MEM).

G Obe, K Brandt, B Beek.   

Abstract

In human leukocyte cultures set up with Eagle's MEM and stimulated with Difco's PHA M, DNA synthesis and mitotic indices were analyzed by means of 3(H)-thymidine autoradiography and cell counting from 23 up to 52 h after culture initiation. Considerable amounts of DNA synthesis and mitoses were found in this time span. This resembles the results found with Ham's F-10 medium. However, the DNA synthesis pattern and the distribution of mitotic indices a higher yield of asynchrony in Eagle's MEM as compared with Ham's F-10 cultures. Proportions of first, second, and third mitoses at 72 h culture time were determined with different methods.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 964988     DOI: 10.1007/BF00286850

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  10 in total

1.  The human leukocyte test system. IV. The RNA-synthesis pattern in the first G1-phase of the cell cycle after stimulation with PHA.

Authors:  B Beek; G Obe
Journal:  Mutat Res       Date:  1975-07       Impact factor: 2.433

2.  The human leukocyte test system. V. DNA synthesis and mitoses in PHA-stimulated 3-day cultures.

Authors:  G Obe; B Beek; G Dudin
Journal:  Humangenetik       Date:  1975-08-25

3.  Amino acid metabolism in mammalian cell cultures.

Authors:  H EAGLE
Journal:  Science       Date:  1959-08-21       Impact factor: 47.728

4.  The human leukocyte test system. I. DNA synthesis and mitoses in PHA-stimulated 2-day cultures.

Authors:  G Dudin; B Beek; G Obe
Journal:  Mutat Res       Date:  1974-05       Impact factor: 2.433

5.  The human leukocyte test system. II. Different sensitivities of sub-populations to a chemical mutagen.

Authors:  B Beek; G Obe
Journal:  Mutat Res       Date:  1974-09       Impact factor: 2.433

6.  Heterogeneous chromosomal radiosensitivity of phytohaemagglutinin-stimulated human blood lymphocytes in culture.

Authors:  J Steffen; A Michalowski
Journal:  Mutat Res       Date:  1973-03       Impact factor: 2.433

7.  Factors influencing chromosome aberration yields in the human peripheral leukocyte system.

Authors:  M A Bender; J G Brewen
Journal:  Mutat Res       Date:  1969 Sep-Oct       Impact factor: 2.433

8.  The human leukocyte test system. III. Premature chromosome condensation from chemically and x-ray induced micronuclei.

Authors:  G Obe; B Beek; V G Vaidya
Journal:  Mutat Res       Date:  1975-01       Impact factor: 2.433

9.  Giemsa technique for the detection of sister chromatid exchanges.

Authors:  J R Korenberg; E F Freedlender
Journal:  Chromosoma       Date:  1974       Impact factor: 4.316

10.  The human leulocyte test system. VII. Further investigations concerning micronucleus-derived premature chromosome condensation.

Authors:  G Obe; B Beek
Journal:  Humangenetik       Date:  1975-11-06
  10 in total
  4 in total

1.  The human leukocyte test system. X. higher sensitivity to X-irradiation in the G0 stage of the cell cycle of early as compared to late replicating cells.

Authors:  B Beek; G Obe
Journal:  Hum Genet       Date:  1976-12-29       Impact factor: 4.132

2.  The RBE of 30 kV X-rays for the induction of dicentric chromosomes in human lymphocytes.

Authors:  R P Virsik; D Harder; I Hansmann
Journal:  Radiat Environ Biophys       Date:  1977-07-29       Impact factor: 1.925

3.  Differential chromosomal radiosensitivity within the first G1-phase of the cell cycle of early-dividing human leukocytes in vitro after stimulation with PHA.

Authors:  B Beek; G Obe
Journal:  Hum Genet       Date:  1977-02-11       Impact factor: 4.132

4.  Sister chromatid exchanges in human leukocyte chromosomes: spontaneous and induced frequencies in early- and late-proliferating cells in vitro.

Authors:  B Beek; G Obe
Journal:  Hum Genet       Date:  1979-05-23       Impact factor: 4.132

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.